XR8-89 is a potent papain-like protease (PL pro ) inhibitor with an IC 50 value of 0.1 μM. XR8-89 induces conformational changes in SARS-COV-2 papain-like protease, inhibiting SARS-CoV-2 replication. XR8-89 can be used for SARS-CoV-2 researchIn VitroXR8-89 induces conformational changes manly in BL2 region and increases the activity against PL pro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:IC50: 0.1 μM (papain-like protease).
Specifications and Purity: ≥97%
Molecular Formula: C29H36N4O2S
Molecular Weight: 504.69
- UPC:
- 41101802
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- X649775-5mg
- CAS:
- 2817811-16-6
- Product Size:
- 5mg
akash.verma@cenmed.com
(732) 447-1115





